Activation markers on monocytes
| Marker | Cellular distribution | Remarks | Monoclonal antibody | Source | |
|---|---|---|---|---|---|
| MPO | neutrophils | increased expression after priming | 4.15 | CLB | |
| monocytes | |||||
| Pr3 | neutrophils | increased expression after priming | 12.8 | CLB | |
| monocytes | |||||
| HLE | neutrophils | increased expression after priming | NP57 | Dako | |
| monocytes | |||||
| CD63 | monocytes | GP53, increased expression after priming | CLB-gran/12,435 | CLB | |
| granulocytes | |||||
| activated platelets | |||||
| CD11b | monocytes | increased expression after priming, subunit of beta2 integrin CD18/ CD11b (Mac-1), ligand for ICAM-1, β glucan, fibrinogen, C3bi. | 2LPM19c | Dako | |
| macrophages | |||||
| granulocytes | |||||
| NK cells | |||||
| CD49d | monocytes | adhesion molecule, subunit of beta1 integrin CD29/CD49d (VLA-4). | HP2/1 | Imm. tech | |
| lymphocytes | |||||
| eosinophils | |||||
| FcγRI (CD64) | monocytes | increased expression after activation, constitutively expressed on monocytes, | 22 | Medarex | |
| granulocytes | |||||
CLB; Central Laboratory for the Bloodtransfusion Service, Amsterdam, the Netherlands, Dako; Dakopatts, Glostrup, Denmark, Imm. tech, Immunotech, Marseilles, France; Medarex, Annandale, USA.